Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dalfampridine After Optic Neuritis to Improve Visual Function in Multiple Sclerosis

NCT01337986 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01337986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01337986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dalfampridine After Optic Neuritis to Improve Visual Function in Multiple Sclerosis
Lead sponsor
Washington University School of Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2013
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, optic neuritis